Market Overview

Morning Market Movers

Related CYTR
Aldoxorubicin Continues To Demonstrate Positive Clinical Activity In Phase 2 Glioblastoma Trial
Mid-Morning Market Update: Markets Open Higher; Lennar Tops Q3 Views
Related DM
Southern Copper, Sears And Others That Insiders Have Been Buying
Benzinga's Top Downgrades

CytRx (NASDAQ: CYTR) rose 29.55% to 2.85 after the company reported that aldoxorubicin demonstrated statistically significant efficacy in the treatment of rapidly growing human brain cancer brains animals.

The Dolan Company (NYSE: DM) shares jumped 16.67% to $2.07 after the company announced its plans to sell two NDeX businesses.

Ambient (NASDAQ: AMBT) jumped 9.79% to $3.14 after the company reported that it has been awarded contract by Consolidated Edison.

WD-40 Company (NASDAQ: WDFC) moved up 8.71% to $62.67 on upbeat FQ3 earnings.

Posted-In: Morning Market MoversNews Intraday Update Markets


Related Articles (CYTR + AMBT)

View Comments and Join the Discussion!

Get Benzinga's Newsletters